Nafazolin

When ATH:
R01AA08

Characteristic.

White or white with a yellowish tinge crystalline powder. It is soluble in water, soluble in alcohol, slightly soluble in acetone, very little — in xloroforme, practically insoluble in hexane.

Pharmacological action.
Alfa adrenomimeticheskoe, vasoconstrictor, antikongestivnoe.

Application.

Coryza, pollen disease, sinusitis, genyantritis, laringit, evstahiit, laryngeal edema allergic genesis and background radiation, hyperemia of the mucosa after surgery on the upper airway, nose bleed, chronic conjunctivitis; rhinoscopy (in combination with a local anesthetic).

Contraindications.

Hypersensitivity, zakrыtougolynaya glaucoma, arterial hypertension, tachycardia, expressed atherosclerosis, severe eye disease, diabetes, thyrotoxicosis, chronic rhinitis, simultaneous reception of MAO inhibitors and ten since the end of their application, childhood (to 1 year).

Side effects.

Local reactions: irritation, reaktivnaя giperemiя; in the long-term use-inflammation of mucous membrane.

Systemic reactions: nausea, headache, increased blood pressure, tachycardia.

Cooperation.

Slows absorption of local anesthetics. Tricyclic antidepressants, maprotiline-increase effect. Incompatible with MAO inhibitors.

Overdose.

Symptoms: declination of fever, bradycardia, increased blood pressure.

Treatment: symptomatic.

Dosing and Administration.

In otorhinolaryngology: intranasally (in each nostril), adults — on 1-3 drops 0.05-0.1% solution 3-4 times a day, older children 1 the year-on 1-2 drops 0,05% or further diluted in distilled water solution.

If nosebleeds: introduction into the nasal cavity swabs, wetted 0,05% solution.

In ophthalmology (use only 0,05% solution): 1-2 drops 0,05% solution into the cavity of the conjunctiva, 1-3 Times a day.

When rhinoscopy to prolong the surface anesthesia: 2-4 Drops 0,1% solution with 1 ml of anesthetic.

Cooperation